Asia-Pacific STD diagnostics market is growing at a CAGR of around 9.4% during the forecast period. The region has the second-highest HIV prevalence. Major countries such as China, India and Indonesia account for around three-quarters of the total number of people living with HIV. There is a huge variation across the region in terms of the incidence of HIV and countries’ responses to the diagnosis and treatment. However, investments by countries with HIV diagnosis and treatment in the region have doubled over the last decade.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-sexually-transmitted-disease-market
There is a significant increase in the incidence and prevalence of genital herpes and genital warts in the region. Gonorrhea is the most dominant STD in the region, with a high incidence of chromosomally-mediated resistant and penicillinase-producing strains comprising around 35%-50% of isolates. Clinical treatment failures due to spectinomycin-resistant gonococci are increasing in the APAC region. Uncontrolled antibiotic sales are responsible for these resistant strains. Further, STDs such as syphilis incidence was declined in 1950, however, it has re-emerged in the APAC region. The incidence of Cancroid is decreasing, while herpes is making up a greater share in the ulcer disease. The high incidence of STDs in this area is an indication of future trends of HIV/AIDS in the APAC region. The Asia-Pacific STD diagnostics market is strongly fueled by the rapid spread of human papilloma virus infection among the female population.
In addition, supportive government initiatives and prevention programs are impacting the growth of Asia-Pacific STD diagnostics market as it has succeeded in reducing new HIV infections across the region. However, late diagnosis remains a key area of concern. Many countries in APAC have disciplinary and stigmatizing laws in place, which prevent members of key affected individuals from accessing services and work to support HIV stigma. According to UNAID (Joint United Nations Program on HIV/AIDS), in 2018, there were approximately 310,000 new infections in the region. The progress in reducing new infections has slowed in recent years and new HIV infections are on the rise in some countries of the region.
A full report of Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-sexually-transmitted-disease-market
Asia-Pacific STD Diagnostics Market Segmentation
By Disease Type
- Chlamydia
- Syphilis
- Gonorrhea
- Herpes Simplex Virus (HSV)
- Human Papilloma Virus (HPV)
- Human Immunodeficiency Virus (HIV)
- Others
By Product
- Laboratory Testing Devices
- Point-of-Care (POC) Testing Devices
By End-user
- Hospitals and Clinics
- Diagnostic Centers
- Homecare
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Abbott Laboratories, Inc.
- AbbVie Inc.
- Becton, Dickinson and Co.
- Biocartis NV
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research